Login to Your Account

Panel: Cardiovascular Risks a Concern

FDA Panel Votes to Support Adolor's GI Postsurgery Drug

By Donna Young

Thursday, January 24, 2008
SILVER SPRING, MD - Federal advisers Wednesday told the FDA that it should approve Adolor Corp.'s Entereg (alvimopan) for short-term use in hospitalized patients following partial large or small bowel resection surgery with primary anastomosis. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription